Related Experiment Video
Updated: May 6, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Endovascular treatment of intracranial atherosclerotic disease
Christopher J Lenart1, Mandy J Binning, Erol Veznedaroglu
1Stroke and Cerebrovascular Center of New Jersey, 750 Brunswick Avenue, Trenton, NJ 08638, USA.
Insights
Stroke, a leading cause of death, involves intracranial atherosclerosis. While treatments like stenting show promise for severe cases, the best approach for symptomatic intracranial atherosclerotic disease remains under debate.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Cardiology
Background:
- Stroke is a major cause of mortality in the US.
- Intracranial atherosclerotic disease contributes significantly to cerebrovascular accidents.
- Established risk factors for this condition are well-documented.
Purpose of the Study:
- To review the current understanding and treatment of intracranial atherosclerosis.
- To evaluate the evolution of medical and endovascular therapies.
- To address the ongoing debate regarding the optimal management of symptomatic intracranial atherosclerotic disease.
Main Methods:
- Review of existing literature on intracranial atherosclerosis treatments.
- Analysis of outcomes from medical, surgical bypass, and endovascular therapies.
- Examination of initial reports on stent placement for high-grade disease.
Main Results:
- Surgical bypass has not demonstrated superiority over medical therapy.
- Endovascular therapies have evolved, including the use of cardiac devices.
- Initial stent placement reports for symptomatic high-grade disease were encouraging.
Conclusions:
- The optimal treatment for symptomatic intracranial atherosclerotic disease is still debated.
- Medical and endovascular approaches continue to evolve.
- Further research is needed to establish definitive treatment guidelines.
Abstract:
Stroke is the third leading cause of death in the United States. Intracranial atherosclerotic disease plays a role in cerebrovascular accidents, with well-characterized modifiable and nonmodifiable risk factors. Surgical bypass has so far not proved to be superior to medical therapy. Both medical and endovascular therapies for intracranial atherosclerosis have evolved since the initial off-label use of cardiac devices for its treatment. Initial reports on the results of stent placement for symptomatic high-grade intracranial atherosclerotic disease were initially encouraging. However, debate remains as to the optimal treatment of symptomatic intracranial atherosclerotic disease.
More Related Videos
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Atherosclerosis III: Management
Ischemic Stroke ll: Pathophysiology